Korean mint 藿香
Pharmaceutical nameAgastachis Herba
The three axes are assessed independently and are never combined into a single score.
KTKP records the origin species as Agastache rugosa (Fisch. et Meyer) O. Kuntze. It has not yet been cross-checked against the Korean Pharmacopoeia, so the identification confidence is not raised to an official code mapping. The same source species also yields 1 other separately registered drug(s) (Agastachis Folium), which must not be conflated. The name most used for this taxon in current literature is Agastache rugosa.
Tradition · what the text describes
탕액편
The sub-section within this volume has not been verified against the original text yet.
The KTKP traditional materia medica record (M0000321) gives the origin species as Agastache rugosa (Fisch. et Meyer) O. Kuntze, the part used as 지상부, and the properties as 무독(無毒), 미온(微溫), 신(辛). It lists 비(脾), 위(胃), 폐(肺) as the channels entered. The same record cites the Donguibogam (1613) as the source for its indications.
Properties & channel entry: 무독(無毒), 미온(微溫), 신(辛) · 비(脾), 위(胃), 폐(肺)
Source species: Agastache rugosa (Fisch. et Meyer) O. Kuntze (지상부)
Modern · documented evidence
Skin Agingevidence for this indication
- The indication was derived automatically from the Condition field of 0 registered trial(s). It reflects what is currently being studied, not a traditional use, and a curator should confirm the label is apt.
Literature
SR 0 · RCT 1 · preclinical 0
0 systematic review(s) and 1 RCT(s) were found. Size and consistency are not yet assessed.
Query used
We publish the exact query behind these counts so you can reproduce them yourself.
SRC:MED AND ((TITLE_ABS:"Agastache rugosa")) AND TITLE_ABS:"Skin Aging"- Comparative Effects of Agastache rugosa Extract and a Complex of Agastache rugosa, Ficus carica, and Lycium barbarum Extracts on Skin Aging: A Randomized, Double-Blind, Placebo-Controlled Trial. (2026 · Comparative Study; Randomized Controlled Trial; Journal Article)
Clinical trials
- NCT00676975 — COMPLETED · PHASE2
- NCT07757724 — COMPLETED · NA
Safety
auto-proposed · unreviewed
- 1 adverse-event or toxicity record(s) were found. This only flags that literature exists — read the abstracts to decide between "caution" and "harm confirmed".
- 1 interaction-related record(s) are retrievable. This flags that literature exists — it is not an interaction checker (§3.4).
- The KTKP record states the following traditional contraindication: 음허화왕자(陰虛火旺者)나 위약욕구(胃弱欲嘔) 및 위열작구자(胃熱作嘔者)는 복용을 기(忌)하고, 중초화성열극(中焦火盛熱極)이나 온병열병(溫病熱病) 또는 음양위가실사(陰陽胃家實邪)로 인한 작구작창자(作嘔作脹者)는 복용을 금(禁)한다.
Adverse-event and toxicity literature
This is not a finding of harm — it lists literature that is retrievable. Read the papers to decide.
- A Combination of Amaranth Protein Hydrolysate and Korean Mint Extract Ameliorates Cisplatin-Induced Nephrotoxicity and Cachexia in CT26 Tumor-Bearing BALB/c Mice. (2026 · research-article; Journal Article)
Interaction literature
This lists literature that is retrievable — it is not a judgement that an interaction exists. Read the papers to decide.
- [Analysis of essential oil in herbal pair Artemisia annua-Agastache rugosa by GC-MS and chemometric resolution method]. (2009 · Journal Article; English Abstract)
Sources
Bridges from here
- In formulas
- 조기산 · 신기산 · 곽향정기산 · 분심기음
- Related patterns
- Qi patterns · Blood deficiency pattern